
The Principal
Mounir
Khouy.
17 years.
One standard.
"Clients don't engage Health Analytika for headcount. They engage for judgment — and the kind of relationships that only come from sustained proximity to global healthcare markets over nearly two decades."
Mounir Khouy is the founder and principal of Health Analytika. He works directly on every engagement — bringing seventeen years of deep industry experience across med-tech, health-tech, and healthcare delivery to every client he chooses to work with.
MK
Mounir Khouy
Founder & Principal — Health Analytika
Med-Tech
Health-Tech
Facility Transformation
Market Entry
Scale-Stage Expansion
Global Healthcare
Experience at a glance
17 Years in the Med-Tech & Health-Tech Industry
Not advisory distance — active, operational experience inside the industry, across the full arc of how products are built, validated, positioned, and scaled in global healthcare markets.
Truly Global Presence
Active relationships and direct market experience spanning North America, the Middle East, Asia-Pacific, Latin America, and Europe — built through years of in-market presence, not remote research.
Two Practice Areas, One Principal
Every Med-Tech and Facilities engagement is led personally by Mounir. Clients are not passed to a team. The experience, judgment, and relationships they engage are the ones they get — every time.
Selective by Design
Mounir works with a limited number of clients at any one time. That is not a constraint — it is the model. The depth of engagement that produces results is not compatible with volume.
Background
Built from
the inside
out.
17+
Years inside the industry
Mounir Khouy did not arrive at healthcare consulting from the outside. He came from within the industry — from years of direct engagement with the companies building the technologies that are reshaping how care is delivered globally.
Over seventeen years working across the med-tech and health-tech industry, Mounir developed something that cannot be acquired quickly: a granular understanding of how healthcare markets actually work — how decisions are made, who makes them, what creates trust in a clinical environment, and what causes even the most promising products to stall between development and adoption.
​
That experience spans every major global healthcare market. North America. The Middle East. Asia-Pacific. Latin America. Europe. In each, he has built genuine relationships with the clinical, commercial, and regulatory stakeholders who determine whether an innovation succeeds or disappears. These are not contacts in a database — they are relationships earned through sustained, credible presence over nearly two decades.
"There is a high level of proactivity in initiating new paths of thinking, planning, and tackling challenges."
Ben Stanton — United Kingdom
Health Analytika is the structure through which Mounir brings that experience to bear — for a select group of organisations that are serious about what they are trying to build or transform. The firm is deliberately not large. It is designed to deliver what a large firm cannot: the undivided attention, direct judgment, and active relationships of someone who has spent seventeen years at the intersection of healthcare innovation and global market reality.
​
The clients who engage Health Analytika are not looking for a report. They are looking for a partner who has already been where they are trying to go — and who can walk the route with them.
What This Means For You
What you get
when you engage
directly.
Every engagement with Health Analytika is an engagement with Mounir Khouy. That is not a limitation — it is the point. Here is what that means in practice.
01
You work with the most experienced person in the room — always
There is no senior partner who sells and a junior team that delivers. The judgment, relationships, and pattern recognition you engage are the ones present in every meeting, on every call, across every decision.
02
Relationships that took 17 years to build — available immediately
The introductions Mounir makes are warm, trusted, and consequential. Building equivalent access independently would take years and significant capital. Engaging Health Analytika compresses that timeline entirely.
03
Pattern recognition across every major global healthcare market
Having navigated market entry, product validation, and facility transformation across multiple continents produces a depth of comparative insight that no single-market firm or first-time entrant can replicate.
04
The candour that only comes without an agenda to protect
An independent principal with no firm politics, no upselling structure, and no incentive beyond the outcome has one job: to tell you what is true and help you act on it. That is a different kind of advice.
Global Presence
Every major
market.
In person.
Mounir's global presence is not a capability statement — it is a history. Each region represents years of direct engagement, in-market relationships, and the cultural and regulatory fluency that only comes from being there.
North America
United States · Primary market for med-tech commercialisation
Active
Middle East
UAE · Saudi Arabia · Kuwait · Bahrain · High-growth healthcare infrastructure
Active
Asia-Pacific
Singapore · Australia · New Zealand · Sophisticated clinical markets
Active
Latin America
Brazil · México · Chile · Colombia · Emerging and established markets
Active
Europe & United Kingdom
Multiple markets · Regulatory and commercial engagement
Active
The right conversation
at the right time
changes everything.
Mounir works with a select number of organisations at any one time. If you are considering a significant move — in market entry, scale, or the transformation of care delivery — the conversation begins here.
A note on engagement: Health Analytika takes on a limited number of clients at any one time. This is intentional. The depth of work that produces results is not compatible with volume. If you are serious about what you are building, we will make the time.